If you are trying to work out whether 10x Genomics is attractively priced or already reflecting a lot of optimism, the starting point is understanding how its current market value lines up with the ...
NeoGenomics is rated a Hold due to the intrinsic value being lower than the current price, and the company's negative net income and FCF. Despite revenue growth and increasing clinical volume, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results